TY - JOUR
T1 - Regulation of peripheral Th/Treg differentiation and suppression of airway inflammation by Nr4a transcription factors
AU - Sekiya, Takashi
AU - Kagawa, Shizuko
AU - Masaki, Katsunori
AU - Fukunaga, Koichi
AU - Yoshimura, Akihiko
AU - Takaki, Satoshi
N1 - Funding Information:
We thank Drs. S. Hori, H. Ichinose, D. Metzger, and P. Chambon for providing us mice. This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) 18H02673 , for Scientific Research on Innovative Areas 19H04822 and 20H04958 , the Takeda Science Foundation , Mochida Memorial Foundation for Medical and Pharmaceutical Research , SENSHIN Medical Research Foundation , and Grant for National Center for Global Health and Medicine ( 20A1005 ) for T.S, and JSPS KAKENHI (S) JP17H06175 and AMED- CREST JP19gm1110009 for A.Y.
Publisher Copyright:
© 2021 The Author(s)
PY - 2021/3/19
Y1 - 2021/3/19
N2 - Helper T (Th) and regulatory T (Treg) cell differentiation programs promote the eradication of pathogens, while minimizing adverse immune reactions. Here, we found that Nr4a family of nuclear receptors supports Treg cell induction and represses Th1 and Th2 cell differentiation from naive CD4+ T cells. Nr4a factors are transiently induced in CD4+ T cells immediately after antigen stimulation, thereby mediating epigenetic changes. In differentiating Treg cells, Nr4a factors mainly upregulated the early responsive genes in the Treg cell-specifying gene set, either directly or in cooperation with Ets family transcription factors. In contrast, Nr4a factors repressed AP-1 activity by interrupting a positive feedback loop for Batf factor expression, thus suppressing Th2 cell-associated genes. In an allergic airway inflammation model, Nr4a factors suppressed the pathogenesis, mediating oral tolerance. Lastly, pharmacological activation of an engineered Nr4a molecule prevented allergic airway inflammation, indicating that Nr4a factors may be novel therapeutic targets for inflammatory diseases.
AB - Helper T (Th) and regulatory T (Treg) cell differentiation programs promote the eradication of pathogens, while minimizing adverse immune reactions. Here, we found that Nr4a family of nuclear receptors supports Treg cell induction and represses Th1 and Th2 cell differentiation from naive CD4+ T cells. Nr4a factors are transiently induced in CD4+ T cells immediately after antigen stimulation, thereby mediating epigenetic changes. In differentiating Treg cells, Nr4a factors mainly upregulated the early responsive genes in the Treg cell-specifying gene set, either directly or in cooperation with Ets family transcription factors. In contrast, Nr4a factors repressed AP-1 activity by interrupting a positive feedback loop for Batf factor expression, thus suppressing Th2 cell-associated genes. In an allergic airway inflammation model, Nr4a factors suppressed the pathogenesis, mediating oral tolerance. Lastly, pharmacological activation of an engineered Nr4a molecule prevented allergic airway inflammation, indicating that Nr4a factors may be novel therapeutic targets for inflammatory diseases.
KW - Biological Sciences
KW - Cell Biology
KW - Immunology
UR - http://www.scopus.com/inward/record.url?scp=85101318591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101318591&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2021.102166
DO - 10.1016/j.isci.2021.102166
M3 - Article
AN - SCOPUS:85101318591
SN - 2589-0042
VL - 24
JO - iScience
JF - iScience
IS - 3
M1 - 102166
ER -